HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH PATENTS FACING OPPOSITIONS
Top patents of HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH facing oppositions at the European Patent Office (EPO)
Patent Number | Grant Date | Patent Title | Expected Expiration Date | Facing Oppositions | Activity Alert |
EP3763820B1 |
22 Dec, 2021
|
Retroviral Transduction Using Poloxamers
|
Feb, 2033
|
1
| |
EP2820138B1 |
28 Oct, 2020
|
Retroviral Transduction Using Poloxamers
|
Feb, 2033
|
1
| |